Holen Sie sich die Stockscreener-App
5.19
7.23%
0.35
Finanzdaten der Bolt Biotherapeutics Inc-Aktie (BOLT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
47.63%
1.804
|
1.222 | - | 1.141 | 1.275 |
Operating Expenses
|
17.42%
11.01
|
13.34 | 16.92 | 17.58 | 23.87 |
| Benefits Costs and Expenses |
100.00%
-
|
12.26 | 15.94 | - | - |
| Costs And Expenses |
10.18%
11.01
|
12.26 | 15.94 | 17.58 | 23.87 |
| Operating Income/Loss |
23.98%
-9.21
|
-12.12 | -16.92 | -16.44 | -22.60 |
| Nonoperating Income/Loss |
39.63%
0.649
|
1.075 | 0.98 | 1.267 | 1.402 |
| Income/Loss From Continuing Operations Before Tax |
116.34%
1.804
|
-11.04 | -15.94 | 1.141 | 1.275 |
| Income/Loss From Continuing Operations After Tax |
22.45%
-8.561
|
-11.04 | -15.94 | -15.18 | -21.20 |
|
Net Income/Loss
|
22.45%
-8.561
|
-11.04 | -15.94 | -15.18 | -21.20 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
95.00%
1.9176
|
38.34 | 0.0341 | 38.25 | 38.13 |
| Diluted Average Shares |
95.00%
1.9176
|
38.34 | 0.0341 | 38.25 | 38.13 |
| Basic Earnings Per Share |
1,438%
-4.46
|
-0.29 | -0.41 | -0.40 | -0.56 |
| Diluted Earnings Per Share |
1,438%
-4.46
|
-0.29 | -0.41 | -0.40 | -0.56 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):